Figure 1: Hysterosalpingogram with metal cone instrument shows obliterated endometrial cavity except for most lower segment after contrast injection
Age |
Number |
Percentage |
˂ 35 years |
1 |
1.63% |
35 to 45 years |
13 |
21.31% |
46 to 55 years |
16 |
26.22% |
56 to 65 yars |
15 |
24.59% |
66 to 75 years |
8 |
13.11% |
˃ 75 years |
5 |
8.19% |
Not specified |
3 |
4.91% |
Table 1: Patient Age Distribution
Sites |
Number |
Percentage |
2/3 proximal vagina |
16 |
26.22% |
1/3 distal vagina |
21 |
34.42% |
Paramters |
44 |
72.13% |
Bladder |
12 |
19.67% |
Rectum |
12 |
19.67% |
Hydronephrosis |
13 |
21.31% |
Pelvic wall |
1 |
1.64% |
Adenomegalies |
35 |
57.37% |
Metastases |
3 |
4.91% |
Table 2:Tumour Extension Based on Sites Affected
FIGO MRI Stage |
Number |
Percentage |
Stage I |
7 |
11.47% |
Stage IIA |
1 |
1.64% |
Stage IIB |
17 |
27.86% |
Stage IIIA |
2 |
3.27% |
Stage IIIB |
19 |
31.14% |
Stage IVA |
7 |
11.47% |
Stage IVB |
3 |
4.91% |
No tumour |
3 |
4.91% |
Fibrosis |
2 |
3.27% |
Total |
61 |
100% |
Table 3: Distribution of Patients Based on FIGO MRI Stages
Figure 1: Hysterosalpingogram with metal cone instrument shows obliterated endometrial cavity except for most lower segment after contrast injection
Figure 2: Hysterosalpingogram with plastic catheter shows obliterated endometrial cavity except for most lower segment after contrast injection
Figure 3: Hystrosalpingogram scout film demonstrates multiple pelvic calcification indicating lymph nodes calcification
Figure 4: Hystrosalpingogram scout film demonstrates multiple pelvic calcification indicating lymph nodes calcification
Figure 5: Hystrosalpingogram scout film demonstrates multiple pelvic calcification indicating lymph nodes calcification
Figures at a glance